Ayşin Kılınç-Toker

7PUBLICATIONS
26CO-AUTHORS
AllergyCardiology (incl. cardiovascular diseases)Intensive carePredictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 12, 2025
Tuberculous Meningitis With Paradoxical Reaction in an Immunocompetent Young Male Treated by Interleukin-1 Receptor Antagonist.

Azade Kanat, Ayşin Kılınç Toker, Zuhal Özer Şimşek

|Apr 18, 2024
CD4+ T-Cell Depression is Linked to the Severity of COVID-19 and Predicts Mortality.

Esma Eryılmaz-Eren, Mustafa Yavuz Köker, Aysegul Ulu-Kılıç

|Nov 21, 2022
Quick COVID-19 Severity Index, CURB-65 and Quick SOFA Scores Comparison in Predicting Mortality and Risk Factors of COVID-19 Patients.

Ayşin Kılınç Toker, İlhami Çelik, İbrahim Toker

|Oct 29, 2021
Low-dose tocilizumab is associated with improved outcome and a low risk of secondary infection in severe COVID-19 pneumonia.

Ilhami Celik, Esma Eryilmaz-Eren, Aysin Kilinc-Toker

|Sep 01, 2021
Retrospective analysis on efficacy of convalescent plasma in acute respiratory distress syndrome due to COVID-19.

Esma Eren, Ayşegül Ulu-Kılıç, Serdal Korkmaz

Pageof 2